| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index.
|
Nat Genet
|
2010
|
23.08
|
|
2
|
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.
|
Nat Genet
|
2010
|
17.89
|
|
3
|
Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations.
|
Nat Genet
|
2009
|
6.39
|
|
4
|
A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk.
|
Nat Genet
|
2008
|
5.49
|
|
5
|
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals.
|
PLoS Genet
|
2012
|
3.21
|
|
6
|
Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus.
|
Nature
|
2011
|
2.59
|
|
7
|
Genome-wide meta-analysis points to CTC1 and ZNF676 as genes regulating telomere homeostasis in humans.
|
Hum Mol Genet
|
2012
|
1.77
|
|
8
|
A genome-wide association search for type 2 diabetes genes in African Americans.
|
PLoS One
|
2012
|
1.72
|
|
9
|
Prevalence of loss-of-function FTO mutations in lean and obese individuals.
|
Diabetes
|
2009
|
1.54
|
|
10
|
Association of genetic Loci with glucose levels in childhood and adolescence: a meta-analysis of over 6,000 children.
|
Diabetes
|
2011
|
1.31
|
|
11
|
Childhood obesity is associated with shorter leukocyte telomere length.
|
J Clin Endocrinol Metab
|
2011
|
1.27
|
|
12
|
Genetic determinants of blood pressure regulation.
|
J Hypertens
|
2005
|
1.12
|
|
13
|
Biological determinants of and reference values for plasma interleukin-8, monocyte chemoattractant protein-1, epidermal growth factor, and vascular endothelial growth factor: Results from the STANISLAS cohort.
|
Clin Chem
|
2006
|
1.05
|
|
14
|
Transcription factor and drug-metabolizing enzyme gene expression in lymphocytes from healthy human subjects.
|
Drug Metab Dispos
|
2007
|
1.01
|
|
15
|
Identification of cis- and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels.
|
Circ Res
|
2011
|
0.97
|
|
16
|
Visfatin, low-grade inflammation and body mass index (BMI).
|
Clin Endocrinol (Oxf)
|
2008
|
0.90
|
|
17
|
A prospective study on the prevalence of metabolic syndrome among healthy french families: two cardiovascular risk factors (HDL cholesterol and tumor necrosis factor-alpha) are revealed in the offspring of parents with metabolic syndrome.
|
Diabetes Care
|
2005
|
0.90
|
|
18
|
Dairy product consumption, calcium intakes, and metabolic syndrome-related factors over 5 years in the STANISLAS study.
|
Nutrition
|
2012
|
0.90
|
|
19
|
What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications?
|
PLoS One
|
2013
|
0.90
|
|
20
|
High prevalence of metabolic syndrome in Iran in comparison with France: what are the components that explain this?
|
Metab Syndr Relat Disord
|
2012
|
0.89
|
|
21
|
The lipoprotein lipase serine 447 stop polymorphism is associated with altered serum carotenoid concentrations in the Stanislas Family Study.
|
J Am Coll Nutr
|
2007
|
0.89
|
|
22
|
A genome-wide association study identifies rs2000999 as a strong genetic determinant of circulating haptoglobin levels.
|
PLoS One
|
2012
|
0.89
|
|
23
|
Expression of inflammatory molecules and associations with BMI in children.
|
Eur J Clin Invest
|
2010
|
0.87
|
|
24
|
Capillary isotachophoresis study of lipoprotein network sensitive to apolipoprotein E phenotype. 1. ApoE distribution between lipoproteins.
|
Mol Cell Biochem
|
2009
|
0.86
|
|
25
|
Collection and storage of human blood cells for mRNA expression profiling: a 15-month stability study.
|
Clin Chem
|
2005
|
0.86
|
|
26
|
Associations of vascular endothelial growth factor (VEGF) with adhesion and inflammation molecules in a healthy population.
|
Cytokine
|
2012
|
0.85
|
|
27
|
Determination of ABCB1 polymorphisms and haplotypes frequencies in a French population.
|
Fundam Clin Pharmacol
|
2007
|
0.85
|
|
28
|
Polymorphism of the 5-HT2A receptor gene and food intakes in children and adolescents: the Stanislas Family Study.
|
Am J Clin Nutr
|
2005
|
0.85
|
|
29
|
Interaction between CYP1A1 T3801C and AHR G1661A polymorphisms according to smoking status on blood pressure in the Stanislas cohort.
|
J Hypertens
|
2006
|
0.83
|
|
30
|
Inter-individual variation of inflammatory markers of cardiovascular risks and diseases.
|
Clin Chem Lab Med
|
2005
|
0.83
|
|
31
|
Novel association approach for variable number tandem repeats (VNTRs) identifies DOCK5 as a susceptibility gene for severe obesity.
|
Hum Mol Genet
|
2012
|
0.83
|
|
32
|
Association of ABCB1 gene polymorphisms with plasma lipid and apolipoprotein concentrations in the STANISLAS cohort.
|
Clin Chim Acta
|
2009
|
0.83
|
|
33
|
Sex-dependent associations of leptin with metabolic syndrome-related variables: the Stanislas study.
|
Obesity (Silver Spring)
|
2009
|
0.83
|
|
34
|
Effect of HMGCoA reductase inhibitors on cytochrome P450 expression in endothelial cell line.
|
J Cardiovasc Pharmacol
|
2007
|
0.82
|
|
35
|
Heritability for plasma VEGF concentration in the Stanislas family study.
|
Ann Hum Genet
|
2007
|
0.81
|
|
36
|
A new single nucleotide polymorphism genotyping method based on gap ligase chain reaction and a microsphere detection assay.
|
Clin Chem Lab Med
|
2008
|
0.81
|
|
37
|
Enzymes and pharmacogenetics of cardiovascular drugs.
|
Clin Chim Acta
|
2007
|
0.81
|
|
38
|
Analysis of the effect of multiple genetic variants of cardiovascular disease risk on insulin concentration variability in healthy adults of the STANISLAS cohort. The role of FGB-455 G/A polymorphism.
|
Atherosclerosis
|
2006
|
0.81
|
|
39
|
Genetic biomarkers of hypertension and future challenges integrating epigenomics.
|
Clin Chim Acta
|
2012
|
0.81
|
|
40
|
Association between factor VII polymorphisms and blood pressure: the Stanislas Cohort.
|
Hypertension
|
2004
|
0.81
|
|
41
|
Association study of gene polymorphisms involved in vascular alterations in elderly hypertensives with subjective memory complaints.
|
Dement Geriatr Cogn Disord
|
2010
|
0.81
|
|
42
|
Personalized therapy and pharmacogenomics: future perspective.
|
Pharmacogenomics
|
2009
|
0.80
|
|
43
|
Klotho KL-VS genotype is involved in blood pressure regulation.
|
Clin Chim Acta
|
2011
|
0.80
|
|
44
|
Cardiovascular diseases and genome-wide association studies.
|
Clin Chim Acta
|
2011
|
0.80
|
|
45
|
Association of classical and related inflammatory markers with high-sensitivity C-reactive protein in healthy individuals: results from the Stanislas cohort.
|
Clin Chem Lab Med
|
2007
|
0.80
|
|
46
|
Genetic determinants of leucocyte telomere length in children: a neglected and challenging field.
|
Paediatr Perinat Epidemiol
|
2015
|
0.80
|
|
47
|
Human formyl peptide receptor 1 C32T SNP interacts with age and is associated with blood pressure levels.
|
Clin Chim Acta
|
2010
|
0.79
|
|
48
|
Natriuretic peptide Val7Met substitution and risk of coronary artery disease in Greek patients with familial hypercholesterolemia.
|
J Clin Lab Anal
|
2006
|
0.79
|
|
49
|
Association between EGF and lipid concentrations: a benefit role in the atherosclerotic process?
|
Clin Chim Acta
|
2009
|
0.79
|
|
50
|
E-selectin genotypes and risk of type 2 diabetes in women: genetic and environmental contributions to serum soluble E-selectin concentrations.
|
Obes Res
|
2005
|
0.78
|
|
51
|
Metabolic syndrome-related composite factors over 5 years in the STANISLAS family study: genetic heritability and common environmental influences.
|
Clin Chim Acta
|
2010
|
0.78
|
|
52
|
Alcohol Consumption, Beverage Preference, and Diet in Middle-Aged Men from the STANISLAS Study.
|
J Nutr Metab
|
2012
|
0.78
|
|
53
|
Visfatin: the link between inflammation and childhood obesity.
|
Diabetes Care
|
2009
|
0.78
|
|
54
|
Relationship between catalase haplotype and arterial aging.
|
Atherosclerosis
|
2013
|
0.78
|
|
55
|
Human formyl peptide receptor 1 (FPR1) c.32C>T SNP is associated with decreased soluble E-selectin levels.
|
Pharmacogenomics
|
2009
|
0.78
|
|
56
|
Association between TNF and IL-1 bloc polymorphisms and plasma MCP-1 concentration.
|
Atherosclerosis
|
2006
|
0.78
|
|
57
|
Association between angiotensin II type 1 receptor gene polymorphism and metabolic syndrome in a young female Iranian population.
|
Arch Med Res
|
2010
|
0.77
|
|
58
|
Statins as effectors of key activities involved in apoE-dependent VLDL metabolism: review and hypothesis.
|
Vascul Pharmacol
|
2007
|
0.77
|
|
59
|
Different genes and polymorphisms affecting high-density lipoprotein cholesterol levels in Greek familial hypercholesterolemia patients.
|
Genet Test
|
2006
|
0.77
|
|
60
|
Leptin expression in Peripheral Blood Mononuclear Cells (PBMCs) is related with blood pressure variability.
|
Clin Chim Acta
|
2008
|
0.77
|
|
61
|
Clinical necessity of partitioning of human plasma haptoglobin reference intervals by recently-discovered rs2000999.
|
Clin Chim Acta
|
2012
|
0.77
|
|
62
|
Epistatic study reveals two genetic interactions in blood pressure regulation.
|
BMC Med Genet
|
2013
|
0.77
|
|
63
|
A common variant highly associated with plasma VEGFA levels also contributes to the variation of both LDL-C and HDL-C.
|
J Lipid Res
|
2012
|
0.76
|
|
64
|
Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers.
|
Eur J Pharmacol
|
2005
|
0.76
|
|
65
|
Genetic profiling of human cell lines used as in vitro model to study cardiovascular pathophysiology and pharmacotoxicology.
|
Cell Biol Toxicol
|
2008
|
0.76
|
|
66
|
Polymorphisms associated with apolipoprotein B levels in Greek patients with familial hypercholesterolemia.
|
Clin Chem Lab Med
|
2006
|
0.76
|
|
67
|
Newly identified synergy between clopidogrel and calcium-channel blockers for blood pressure regulation possibly involves CYP2C19 rs4244285.
|
Int J Cardiol
|
2013
|
0.76
|
|
68
|
Clinical interest of point-of-care pharmacogenomic testing: clopidogrel behind warfarin.
|
Pharmacogenomics
|
2012
|
0.76
|
|
69
|
Adipokine expression in adipose tissue and in peripheral blood mononuclear cells in children Correlation with BMI and fatty acid content.
|
Clin Chim Acta
|
2009
|
0.75
|
|
70
|
Lack of association between EGF 61A>G polymorphism and plasma EGF concentration in the STANISLAS family study.
|
J Invest Dermatol
|
2006
|
0.75
|
|
71
|
Influence of genetic variations on levels of inflammatory markers of healthy subjects at baseline and one week after clopidogrel therapy; results of a preliminary study.
|
Int J Mol Sci
|
2013
|
0.75
|
|
72
|
Functional epistatic interaction between rs6046G>A in F7 and rs5355C>T in SELE modifies systolic blood pressure levels.
|
PLoS One
|
2012
|
0.75
|
|
73
|
Pharmacogenomics: from cell to clinic (Part 1).
|
Pharmacogenomics
|
2014
|
0.75
|
|
74
|
Common mutations and polymorphisms predicting adverse cardiovascular events: current view.
|
Pharmacogenomics
|
2012
|
0.75
|
|
75
|
Conference Scene: Systems biology and personalized health science and translation.
|
Pharmacogenomics
|
2013
|
0.75
|
|
76
|
[Preanalytical variations of proteic biomarkers].
|
Med Sci (Paris)
|
2007
|
0.75
|
|
77
|
Genetic profiling in healthy subjects from the Stanislas cohort based on 24 polymorphisms: effects on biological variables.
|
Clin Chem Lab Med
|
2008
|
0.75
|
|
78
|
Genetic and environmental contributions to serum ascorbic acid concentrations: the Stanislas Family Study.
|
Br J Nutr
|
2006
|
0.75
|
|
79
|
Genetic determined low response to thienopyridines is associated with higher systemic inflammation in smokers.
|
Pharmacogenomics
|
2015
|
0.75
|
|
80
|
Conference scene: pharmacogenomics: from cell to clinic (part 2).
|
Pharmacogenomics
|
2014
|
0.75
|
|
81
|
Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.
|
Pharmacogenomics
|
2011
|
0.75
|
|
82
|
Capillary isotachophoresis study of lipoprotein network sensitive to apolipoprotein E phenotype. 2. ApoE and apoC-III relations in triglyceride clearance.
|
Mol Cell Biochem
|
2009
|
0.75
|
|
83
|
Biological and genetic factors associated with ABCB1 and pregnane-X-receptor expressions in peripheral blood mononuclear cells in the STANISLAS cohort.
|
Drug Metabol Drug Interact
|
2011
|
0.75
|
|
84
|
Drug metabolizing enzymes and transporters mRNA in peripheral blood mononuclear cells of healthy subjects: biological variations and importance of pre-analytical steps.
|
Curr Drug Metab
|
2009
|
0.75
|